A model system for assessing and comparing the ability of exon microarray and tag sequencing to detect genes specific for malignant B-cells
Maria Bro Kloster(Aalborg University Hospital), Martin Bøgsted(Chr. Hansen (Denmark)), Mette Nyegaard(Statens Serum Institut), Mads Sønderkær(Aalborg University), María Rodrigo-Domingo(Chr. Hansen (Denmark)), Kåre Lehmann Nielsen(Brandtex (Denmark)), Alexander Schmitz(Chr. Hansen (Denmark)), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Steffen Falgreen(Chr. Hansen (Denmark)), Karen Dybkær(Aalborg University Hospital), Anders Ellern Bilgrau(Chr. Hansen (Denmark)), Kim Steve Bergkvist(Chr. Hansen (Denmark))
Cited by 1